Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3556 AL 3570

Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases

Scuderi SA, Ardizzone A, Paterniti I, Esposito E, Campolo M.

Antioxidants (Basel). 2020 Jul 17;9(7):630. doi: 10.3390/antiox9070630.

Somatic mutations in neurodegeneration: An update

Proukakis C.

Neurobiol Dis. 2020 Oct;144:105021. doi: 10.1016/j.nbd.2020.105021. Epub 2020 Jul 24.

Alzheimer's Disease, Inflammation, and the Role of Antioxidants

Sinyor B, Mineo J, Ochner C.

J Alzheimers Dis Rep. 2020 Jun 16;4(1):175-183. doi: 10.3233/ADR-200171.

Gene therapy and immunotherapy as promising strategies to combat Huntington's disease-associated neurodegeneration: emphasis on recent updates and future perspectives

Jamwal S, Elsworth JD, Rahi V, Kumar P.

Expert Rev Neurother. 2020 Nov;20(11):1123-1141. doi: 10.1080/14737175.2020.1801424. Epub 2020 Aug 5.

Effects of rosmarinic acid on nervous system disorders: an updated review

Ghasemzadeh Rahbardar M, Hosseinzadeh H.

Naunyn Schmiedebergs Arch Pharmacol. 2020 Oct;393(10):1779-1795. doi: 10.1007/s00210-020-01935-w. Epub 2020 Jul 28.

The Role of Neurovascular System in Neurodegenerative Diseases

Ahmad A, Patel V, Xiao J, Khan MM.

Mol Neurobiol. 2020 Nov;57(11):4373-4393. doi: 10.1007/s12035-020-02023-z. Epub 2020 Jul 28.

Epigenomic Remodeling in Huntington's Disease-Master or Servant?

Zimmer-Bensch G.

Epigenomes. 2020 Jul 31;4(3):15. doi: 10.3390/epigenomes4030015.

CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases

Karimian A, Gorjizadeh N, Alemi F, Asemi Z, Azizian K, Soleimanpour J, Malakouti F, Targhazeh N, Majidinia M, Yousefi B.

Life Sci. 2020 Oct 15;259:118165. doi: 10.1016/j.lfs.2020.118165. Epub 2020 Jul 29.

Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms

Fifel K, Videnovic A.

Neurobiol Dis. 2020 Oct;144:105029. doi: 10.1016/j.nbd.2020.105029. Epub 2020 Jul 28.

Incidence and prevalence of Huntington disease (HD) in the Sultanate of Oman: the first Middle East post-HTT service-based study

Squitieri F, Maffi S, Al Harasi S, Al Salmi Q, D'Alessio B, Capelli G, Mazza T.

J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1359-1360. doi: 10.1136/jnnp-2020-323241. Epub 2020 Jul 31.

Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications

Taheri Y, Suleria HAR, Martins N, Sytar O, Beyatli A, Yeskaliyeva B, Seitimova G, Salehi B, Semwal P, Painuli S, Kumar A, Azzini E, Martorell M, Setzer WN, Maroyi A, Sharifi-Rad J.

BMC Complement Med Ther. 2020 Aug 1;20(1):241. doi: 10.1186/s12906-020-03033-z.

Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases

Smith SK, Musiek ES.

Int Rev Neurobiol. 2020;154:393-412. doi: 10.1016/bs.irn.2020.02.005. Epub 2020 Jul 10.

Huntingtin-lowering strategies for Huntington's disease

Barker RA, Fujimaki M, Rogers P, Rubinsztein DC.

Expert Opin Investig Drugs. 2020 Oct;29(10):1125-1132. doi: 10.1080/13543784.2020.1804552. Epub 2020 Aug 14.

De novo nose-pinching stereotypy with somnolence: Clues to autoimmune encephalitis

Garg D, Agarwal A, Bhagyawant R, Sikand TS, Singh AK.

J Neuroimmunol. 2020 Oct 15;347:577348. doi: 10.1016/j.jneuroim.2020.577348. Epub 2020 Jul 30.

Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain

Brimson JM, Brimson S, Chomchoei C, Tencomnao T.

Expert Opin Ther Targets. 2020 Oct;24(10):1009-1028. doi: 10.1080/14728222.2020.1805435. Epub 2020 Aug 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias